Physician profile
Michael D Mcnamara
NPI 1861477259
$754,106.92
in general payments reported to CMS, 2019-2025
22 companies · $256K in 2025
The $256K reported for 2025 was more than what 99% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $15K · 2021: $55K · 2022: $78K · 2023: $111K · 2024: $164K · 2025: $256K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $368K · Consulting Fee: $64K · Travel and Lodging: $56K · Food and Beverage: $22K · Honoraria: $22K · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $367,520.20 |
| Consulting Fee | $63,631.25 |
| Travel and Lodging | $56,200.61 |
| Food and Beverage | $21,804.14 |
| Honoraria | $21,725.00 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $217,773.92 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $149,895.11 | 2019-2025 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $100,136.36 | 2024-2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $81,420.22 | 2021-2025 | Caplyta |
| Alkermes, INC. | $69,000.85 | 2021-2025 | Lybalvi, Vivitrol, Aristada |
| Teva Pharmaceuticals USA, INC. | $49,247.20 | 2019-2025 | Uzedy, Austedo, Austedo Xr |
| Abbvie INC. | $34,482.90 | 2021-2025 | |
| Axsome Therapeutics, INC. | $24,253.85 | 2023-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $15,424.38 | 2019-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Allergan, INC. | $7,977.62 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $1,664.97 | 2019-2025 | Fanapt, Hetlioz |
| Indivior INC. | $1,281.40 | 2019-2023 | Perseris |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $653.08 | 2019-2025 | Rexulti, Abilify Maintena |
| Sage Therapeutics, LLC | $284.83 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $190.57 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $124.99 | 2019 | |
| Novo Nordisk INC | $124.23 | 2025 | Wegovy |
| Janssen Scientific Affairs, LLC | $61.18 | 2025 | Invega Sustenna |
| Amgen INC. | $41.06 | 2019 | |
| Luye Pharma (USA) Ltd. | $31.38 | 2025 | Erzofri Extended-Release |
| Sanofi-Aventis U.S. LLC | $22.79 | 2024 | |
| Lundbeck LLC | $14.03 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcnamara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.